Literature DB >> 24650700

The chemistry and biology of febrifugine and halofuginone.

Noel P McLaughlin1, Paul Evans2, Mark Pines3.   

Abstract

The trans-2,3-disubstituted piperidine, quinazolinone-containing natural product febrifugine (also known as dichroine B) and its synthetic analogue, halofuginone, possess antimalarial activity. More recently studies have also shown that halofuginone acts as an agent capable of reducing fibrosis, an indication with clinical relevance for several disease states. This review summarizes historical isolation studies and the chemistry performed which culminated in the correct structural elucidation of naturally occurring febrifugine and its isomer isofebrifugine. It also includes the range of febrifugine analogues prepared for antimalarial evaluation, including halofuginone. Finally, a section detailing current opinion in the field of halofuginone's human biology is included.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Hydroxypiperidine; Antimalarial; Fibrosis; Isomerization; Natural product; Quinazolinone

Mesh:

Substances:

Year:  2014        PMID: 24650700     DOI: 10.1016/j.bmc.2014.02.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α Signaling.

Authors:  Lola Fagbami; Amy A Deik; Kritika Singh; Sofia A Santos; Jonathan D Herman; Selina E Bopp; Amanda K Lukens; Clary B Clish; Dyann F Wirth; Ralph Mazitschek
Journal:  ACS Infect Dis       Date:  2019-02-21       Impact factor: 5.084

Review 2.  Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

Authors:  Mark Pines
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Antimalarial Natural Products.

Authors:  David G I Kingston; Maria Belen Cassera
Journal:  Prog Chem Org Nat Prod       Date:  2022

4.  Effects of corticosteroids vs halofuginone on vocal fold wound healing in an ovine model.

Authors:  Jacqueline Allen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-10

5.  Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model.

Authors:  Faezeh Koohestani; Wenan Qiang; Amy L MacNeill; Stacy A Druschitz; Vanida A Serna; Malavika Adur; Takeshi Kurita; Romana A Nowak
Journal:  Hum Reprod       Date:  2016-04-29       Impact factor: 6.918

6.  Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.

Authors:  Sibo Huo; Huiqiu Yu; Chusheng Li; Jiayu Zhang; Tongjun Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

7.  A novel autoregulatory loop between the Gcn2-Atf4 pathway and (L)-Proline [corrected] metabolism controls stem cell identity.

Authors:  C D'Aniello; A Fico; L Casalino; O Guardiola; G Di Napoli; F Cermola; D De Cesare; R Tatè; G Cobellis; E J Patriarca; G Minchiotti
Journal:  Cell Death Differ       Date:  2015-04-10       Impact factor: 15.828

8.  Low‑dose halofuginone inhibits the synthesis of type I collagen without influencing type II collagen in the extracellular matrix of chondrocytes.

Authors:  Zeng Li; Hao Fei; Zhen Wang; Tianyi Zhu
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

9.  Stereoselective nucleophilic addition reactions to cyclic N-acyliminium ions using the indirect cation pool method: Elucidation of stereoselectivity by spectroscopic conformational analysis and DFT calculations.

Authors:  Koichi Mitsudo; Junya Yamamoto; Tomoya Akagi; Atsuhiro Yamashita; Masahiro Haisa; Kazuki Yoshioka; Hiroki Mandai; Koji Ueoka; Christian Hempel; Jun-Ichi Yoshida; Seiji Suga
Journal:  Beilstein J Org Chem       Date:  2018-05-24       Impact factor: 2.883

10.  Toxicological evaluation of the ultrasonic extract from Dichroae radix in mice and wistar rats.

Authors:  Ling Wang; Zhiting Guo; Dongan Cui; Shahbaz Ul Haq; Wenzhu Guo; Feng Yang; Hang Zhang
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.